ClinicalTrials.Veeva

Menu

Bioavailability of Potassium From Potatoes and Potassium Gluconate

Purdue University logo

Purdue University

Status

Completed

Conditions

Potassium Bioavailability
Blood Pressure

Treatments

Dietary Supplement: Low dose potato
Dietary Supplement: High dose potato
Dietary Supplement: Medium dose potassium gluconate
Dietary Supplement: High dose French fries
Dietary Supplement: Medium dose potato
Dietary Supplement: Basal diet control
Dietary Supplement: High dose potassium gluconate
Dietary Supplement: Low dose potassium gluconate
Dietary Supplement: Placebo control

Study type

Interventional

Funder types

Other

Identifiers

NCT01881295
1301013174

Details and patient eligibility

About

This study is designed to compare the effect of sources of potassium on uptake and the effect of potassium on blood pressure.

Full description

The study will compare uptake of potassium from three different doses and sources; supplements (720, 1440 and 2160 mg) potatoes (720, 1440 and 2160 mg) or French fries (2160 mg).

During 9 phases, participants will consume a controlled diet with the supplements, potato or french fries (every other week for 5 days). On the 4th day, blood and urine samples will be taken to monitor potassium uptake and excretion. Measures of blood pressure will be analyzed at defined time points throughout the intervention.

Enrollment

45 patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Able to adhere to the visit schedule, protocol requirements and available to complete the study
  • Normotensive men and women
  • Aged 20-60 years
  • BMI of 15-35

Exclusion criteria

  • Medication to treat hypertension or hypotension
  • Medication known to affect electrolyte metabolism or contain high levels of potassium or sodium
  • smoke cigarettes or use illegal drugs
  • Hypertension or hypotension
  • Diseases known to affect potassium metabolism
  • Pregnant
  • Allergic to nuts

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

45 participants in 9 patient groups, including a placebo group

Placebo control
Placebo Comparator group
Description:
Subjects will consume tablets containing no potassium in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: Placebo control
Low dose potassium gluconate
Experimental group
Description:
Subjects will consume 720 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: Low dose potassium gluconate
Medium dose potassium gluconate
Experimental group
Description:
Subjects will consume 1440 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: Medium dose potassium gluconate
High dose potassium gluconate
Experimental group
Description:
Subjects will consume 2160 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: High dose potassium gluconate
Low dose potato
Experimental group
Description:
Subjects will consume 720 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: Low dose potato
Medium dose potato
Experimental group
Description:
Subjects will consume 1440 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: Medium dose potato
High dose potato
Experimental group
Description:
Subjects will consume 2160 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: High dose potato
High dose French fries
Experimental group
Description:
Subjects will consume 2160 mg potassium in the form of french fries daily in addition to a basal diet containing 2336 mg potassium
Treatment:
Dietary Supplement: High dose French fries
Basal diet control
Experimental group
Description:
Subjects will consume a basal diet containing 2336 mg potassium daily
Treatment:
Dietary Supplement: Basal diet control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems